Nikki Robas

Nikki is VP of Drug Discovery responsible for leading projects from AI -enabled target identification and validation through to clinical candidate selection . Prior to joining BenevolentAI, Nikki spent 15 years at Pfizer working across a range of therapeutic areas from target identification to early clinical trials, followed by time in the biotech and medical research charity sectors with a focus on translational medicine.